申请人:Takara Shuzo Co, Ltd.
公开号:EP1106624A1
公开(公告)日:2001-06-13
5-Membered ring compounds represented by general formula (I), optically active isomers thereof or salts of the same. These compounds have physiological activities including a carcinostatic effect. In said formula the bond shown by the dotted line in the 5-membered ring represents that this 5-membered ring may be either a cyclopentene ring having a double bond or a saturated cyclopentane ring, and when the 5-membered ring is a cyclopentene ring, X is OR1, Y is =O and Z is H, and when it is a cyclopentane ring, X is =O, Y is OR2 and Z is OR3, (wherein R1 is R4 or -(CO)-R5; R2 is H, -R6 or -(CO)-R7; and R3 is H, R8 or (CO)-R9 (wherein R4, R5, R6, R7, R8 and R9 are the same or different and each represents an aliphatic, aromatic or aliphatic aromatic group, and R5, R7 and R9 may be each H), provided that the case where R2=R3=H is excluded); and W represents a residue obtained by eliminating SH from an SH-containing compound.
通式 (I) 所代表的五元环化合物、其光学活性异构体或其盐类。这些化合物具有生理活性,包括致癌作用。在所述通式中,5 元环中以虚线表示的键代表该 5 元环可以是具有双键的环戊烯环或饱和环戊烷环,当 5 元环是环戊烯环时,X 是 OR1,Y 是 =O,Z 是 H,当它是环戊烷环时,X 是 =O,Y 是 OR2,Z 是 OR3,(其中 R1 是 R4 或-(CO)-R5;R2是H、-R6或-(CO)-R7;以及R3是H、R8或(CO)-R9(其中R4、R5、R6、R7、R8和R9相同或不同,且各自代表脂肪族、芳香族或脂肪芳香族基团,R5、R7和R9可以各自是H),但不包括R2=R3=H的情况);以及W代表通过从含SH的化合物中消除SH而得到的残留物。